Journal of the National Cancer Institute (JNCI) |
Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer |
avr. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Coffee Consumption and Risk of Gallbladder Cancer in a Prospective Study |
mar. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy |
mai. 18 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced Pancreatic Adenocarcinoma |
oct. 17 |
3 ♥ |
Carcinome hépatocellaire (CHC) |
Journal of the National Cancer Institute (JNCI) |
Limited Use of Adjuvant Therapy in Patients With Resected Gallbladder Cancer Despite a Strong Association With Survival. |
juil. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project |
juin. 18 |
2 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer. |
déc. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Aspirin and Risk of Gastric Cancer After Helicobacter pylori Eradication: A Territory-Wide Study |
juil. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis |
aoû. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Low-fat Dietary Pattern and Pancreatic Cancer Risk in the Women's Health Initiative Dietary Modification Randomized Controlled Trial |
Jan. 18 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Changing Landscape of Liver Cancer in California: A Glimpse Into the Future of Liver Cancer in the United States |
déc. 18 |
1 ♥ |
Carcinome hépatocellulaire (CHC) |
Journal of the National Cancer Institute (JNCI) |
Risk of Advanced Neoplasia Using the National Cancer Institute’s Colorectal Cancer Risk Assessment Tool |
aoû. 16 |
2 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity |
mai. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib |
oct. 17 |
3 ♥ |
Cancers autres |
British journal of Cancer |
A randomised phase II study of second-line XELIRI regimen versus irinotecan monotherapy in advanced biliary tract cancer patients progressed on gemcitabine and cisplatin |
aoû. 18 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Prediabetes and diabetes in relation to risk of gastric adenocarcinoma |
juin. 19 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers |
aoû. 16 |
2 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project |
juin. 17 |
2 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations Open |
oct. 17 |
2 ♥ |
Cancers autres |
British journal of Cancer |
Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab |
oct. 16 |
1 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer |
juil. 18 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP) |
juil. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
British journal of Cancer |
Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach |
juin. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2) |
sep. 15 |
2 ♥ |
Cancers autres (hors CCR et CHC), Œsophage/Estomac |
British journal of Cancer |
Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer |
nov. 17 |
3 ♥ |
Cancers autres |